Package 43063-730-14

{"route": ["ORAL"], "spl_id": "414b28cc-0de6-e201-e063-6294a90addbf", "openfda": {"upc": ["0343063730904"], "unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["1a888812-2867-4dd3-b56e-2d98da837d1f"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-730-10)", "package_ndc": "43063-730-10", "marketing_start_date": "20170119"}, {"sample": false, "description": "14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-730-14)", "package_ndc": "43063-730-14", "marketing_start_date": "20161129"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-730-90)", "package_ndc": "43063-730-90", "marketing_start_date": "20190208"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "43063-730_414b28cc-0de6-e201-e063-6294a90addbf", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "43063-730", "generic_name": "Valacyclovir Hydrochloride", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA090682", "marketing_category": "ANDA", "marketing_start_date": "20100524", "listing_expiration_date": "20261231"}